Vontier Corp financial statements

Income statement, balance sheet and cash flow statement for the last 8 fiscal years, taken from the XBRL data Vontier Corp files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2018	FY2020	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	2,666	2,772	2,705	2,991	3,184	3,095	2,979	3,076
Cost of revenue	1,531	1,581	1,517	1,658	1,756
Gross profit	1,135	1,191	1,188	1,333	1,428
Research and development	136	136	126	129	145	164	178	176
Selling, general and administrative	499	491	508	579	628	643	630	639
Operating income	500	563	468	582	578	543	537	562
Interest expense			5.9	37.1	67.5	94.7
Other non-operating income	-0.7	-0.6	2.1	-0.4	-4.9	-0.6	-1.9	2.9
Pre-tax income	507	566	460	534	527	484	498	508
Income tax	122	129	118	121	126	107	75.4	102
Net income	386	437	342	413	401	377	422	406
EBITDA	586	648	547	628	619	587	584	613
EPS, basic	2.29	2.59	2.03	2.44	2.50	2.43	2.76	2.77
EPS, diluted	2.29	2.59	2.02	2.43	2.49	2.42	2.75	2.76
Shares, basic (weighted)	168	168	168	169	161	155	153	147
Shares, diluted (weighted)	168	168	169	170	161	156	154	147
Dividend per share				0.03	0.03	0.10	0.10	0.10

Balance sheet

	FY2018	FY2020	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash and equivalents	0	0	381	573	205	341	356	492
Receivables		491	447	481	515	498	526	527
Inventory		224	234	287	346	297	338	327
Other current assets		111	121	137	153	141	150	146
Total current assets		825	1,182	1,478	1,385	1,333	1,370	1,492
Property, plant and equipment		102	96.8	101	92.1	102	120	130
Lease right-of-use assets		37.8	40.1	45.4	44.5	47	46.8	34.4
Goodwill	1,140	1,158	1,092	1,667	1,739	1,742	1,726	1,758
Intangible assets		274	251	616	650	568	487	412
Other non-current assets		173	178	201	184	225	269	258
Total assets		2,829	3,073	4,350	4,343	4,294	4,311	4,369
Accounts payable		319	367	425	431	367	378	362
Accrued liabilities		319	448	492	438	436	463	410
Deferred revenue		87	87.6	134	135	132	139	102
Short-term debt		16.8	10.9	3.7	4.6	107	52.3	502
Total current liabilities		668	838	933	930	955	909	1,289
Long-term debt		24.6	1,795	2,584	2,586	2,189	2,092	1,594
Lease liabilities		25.2	30.5	35.6	34	37.1	36.6	24.8
Other non-current liabilities		296	217	223	214	217	213	210
Total liabilities		1,030	2,881	3,776	3,764	3,398	3,251	3,118
Total debt		24.6	1,795	2,584	2,586	2,289	2,142	2,094
Paid-in capital		0	7.6	1.5	27.6	56.8	83	112
Retained earnings		0	-13.6	387	771	1,132	1,539	1,931
Treasury stock				0	-328	-403	-627	-930
Other comprehensive income		149	194	182	106	105	56	132
Shareholders' equity		1,811	188	570	577	890	1,051	1,244
Minority interests		4.9	3.9	3.8	3	5.2	8.8	7
Total equity	1,793	1,799	192	574	580	896	1,060	1,251
Total liabilities and equity		2,829	3,073	4,350	4,343	4,294	4,311	4,369
Shares outstanding		0	168	169	156	154	149	142

Cash flow statement

	FY2018	FY2020	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Net income	386	437	342	413	401	377	422	406
Depreciation and amortization	86.4	84.5	78.3	45.9	40.9	43.8	47.4	51.1
Stock-based compensation	13.8	13.1	22.5	25.5	24.3	31.5	31.6	30.1
Change in receivables	-194	-112	-92.8	-140	-217	-148	-204	-132
Change in inventory	-37.9	25.3	-7	-34.6	-74.3	48.9	-48.5	10.9
Change in payables	16	2	44.1	45.6	21.3	-66.8	14.9	-24.3
Cash from operations	421	545	691	481	321	455	428	511
Capital expenditures	-42.4	-38	-35.7	-47.8	-60	-60.1	-82.7	-69.9
Acquisitions		0	0	-956	-278	0	0	-10.9
Cash from investing	-123	-40.3	-41.7	-1,008	-330	69.3	-11.4	-20.7
Debt issued	0	0	1,800	2,187	1,167	0	0	83.3
Debt repaid		0	0	-1,400	-1,167	-300	-150	-133
Stock issued	0	0	1.6	7.5	2.5	10.4	17	10
Share buybacks			0	0	-328	-74.7	-225	-300
Dividends paid		0	0	-12.7	-15.9	-15.5	-15.2	-14.7
Cash from financing	-291	-500	-284	726	-348	-388	-392	-371
Exchange rate effect	-7.9	-5.1	14.8	-6.8	-11.5	-0.1	-8.3	16.8
Net change in cash	0	0	381	192	-368	136	15.5	136
Free cash flow	379	507	656	433	261	395	345	441
Interest paid					67.5	94.7	75.6	69.6
Income taxes paid			4.6		167	126	93.5	126

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to July 3, 2026; growth uses fiscal years. Valuation uses the share price of $31.48 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Operating margin	18.8%	Operating income / revenue.
EBITDA margin	20.5%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	14.4%	Pre-tax income / revenue.
Net margin	11.3%	Net income / revenue.
FCF margin	12.5%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	15.1%	Cash from operations / revenue.
Effective tax rate	21.1%	Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)	29.2%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	8.6%	Net income / average total assets.
Return on invested capital (ROIC)	18.0%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
R&D / revenue	5.4%	Research and development expense / revenue.
SG&A / revenue	20.8%	Selling, general and administrative expense / revenue.
Stock-based pay / revenue	1.0%	Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue	2.6%	Capital expenditures / revenue.
D&A / revenue	1.7%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	3.2%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	-1.2%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	2.6%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y	4.6%	Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y	-0.9%	Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 5y	3.7%	Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y	4.8%	EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y	-0.3%	Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y	2.3%	Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y	-3.8%	Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y	0.4%	Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income CAGR, 5y	3.5%	Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS growth, 1y	0.4%	EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y	3.5%	Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS CAGR, 5y	6.4%	Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y	19.5%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y	16.7%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y	-5.9%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y	27.9%	Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y	19.1%	Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 5y	-7.6%	Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Dividend per share growth, 1y	0.0%	Dividend per share vs the same period a year earlier. Only from a positive base.
Dividend per share CAGR, 3y	58.7%	Compound annual growth of dividend per share over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value growth, 1y	18.4%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	29.2%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	46.0%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	1.4%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	0.2%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	7.3%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	-4.2%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	-2.9%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	-2.7%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	1.25x	Current assets / current liabilities.
Quick ratio	0.81x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.26x	(Cash + short-term investments) / current liabilities.
Debt / equity	1.34x	Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets	39.6%	Total debt / total assets.
Liabilities / assets	70.2%	Total liabilities / total assets.
Net debt	$1.33B	Total debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA	2.12x	Net debt / EBITDA (twelve months), when EBITDA is positive.
Working capital	$257.9M	Current assets - current liabilities.
Goodwill and intangibles / assets	49.1%	(Goodwill + intangible assets) / total assets.
Tangible book value	-$787.1M	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	0.76x	Revenue / average total assets.
Fixed asset turnover	21.3x	Revenue / average property, plant and equipment.
Receivables turnover	5.48x	Revenue / average receivables.
Days sales outstanding	67 days	365 x average receivables / revenue.
FCF conversion	110.6%	Free cash flow / net income, when net income is positive.
Capex / operating cash flow	17.0%	Capital expenditures / cash from operations, when that is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	$2.49	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$21.95	Revenue / diluted weighted shares.
FCF per share	$2.75	Free cash flow / diluted weighted shares.
Operating cash flow per share	$3.31	Cash from operations / diluted weighted shares.
Book value per share	$8.74	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	-$5.77	Tangible book value / shares outstanding.
Cash per share	$1.95	(Cash + short-term investments) / shares outstanding.
Payout ratio	4.1%	Dividends paid / net income, when net income is positive.
Dividends / FCF	3.7%	Dividends paid / free cash flow, when free cash flow is positive.
Buybacks / FCF	102.7%	Share buybacks / free cash flow, when free cash flow is positive.

Valuation

Metric	Value	How it is calculated
Market cap	$4.26B	Share price x shares outstanding.
Enterprise value	$5.59B	Market cap + total debt - cash - short-term investments.
P/E	12.2x	Market cap / net income. Only when net income is positive.
P/S	1.39x	Market cap / revenue.
P/B	3.57x	Market cap / shareholders' equity. Only when equity is positive.
P/FCF	11.1x	Market cap / free cash flow. Only when free cash flow is positive.
P/OCF	9.18x	Market cap / cash from operations, when positive.
EV/Sales	1.82x	Enterprise value / revenue.
EV/EBIT	9.69x	Enterprise value / operating income, when both are positive.
EV/EBITDA	8.90x	Enterprise value / EBITDA, when both are positive.
EV/FCF	14.5x	Enterprise value / free cash flow, when both are positive.
FCF yield	9.0%	Free cash flow / market cap.
Earnings yield	8.2%	Net income / market cap (the inverse of P/E).
Dividend yield	0.3%	Dividends paid over the period / market cap.
Shareholder yield	9.6%	(Dividends paid + share buybacks) / market cap.
PEG	3.50x	P/E / EPS growth per year over 3 years (in percent). Only when both are positive.

What was Vontier Corp's revenue in fiscal 2025?

Vontier Corp reported revenue of $3.08B for fiscal 2025, 3.2% higher than the year before.

Was Vontier Corp profitable in fiscal 2025?

Yes. Net income was $406.1M, a net margin of 13.2%.

How much free cash flow did Vontier Corp generate in fiscal 2025?

Cash from operations of $511.0M minus capital expenditures of $69.9M left free cash flow of $441.1M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to Vontier Corp